Wondering how to fight COVID-19? Take a look at this promising intravenous vitamin C research trial to treat COVID-19!
Want to learn about how vitamin C and IV drip therapy can help you fight coronavirus? Then, you’ve come to the right place.
China, the country where the first case of the current pandemic was recorded, used vitamin C in its fight against COVID-19. The first research trial took place in China in which 12,000 to 24,000 mg of vitamin C was administered via IV to coronavirus patients. After the success of this study, another research trial of IV vitamin C was broadcasted in China on 13th February, 2020. Consequently, a third research trial for IV vitamin C for coronavirus was also approved on 21st February, 2020.
Why did Vitamin C prove to be so important? Well, let’s take a look at some benefits and curing properties of vitamin C:
Vitamin C Antiviral and Curative Properties
According to research, the antiviral properties of vitamin C reduce the mortality in children and adults. Vitamin C is also used to treat and cure herpes, infectious mononucleosis, hepatitis, chickenpox and measles, trichinosis, urethritis, cancer, and arthritis. It is also used in treating high cholesterol, arteriosclerosis, burns, glaucoma, heatstroke, slipped disc, and heavy metal poisonings.
The Vital Need for an Intravenous Vitamin C Administration
According to Dr. Richard Cheng MD Ph.D., head of the IV vitamin C studies, patients who had moderate to severe symptoms of COVID-19 were given about 6,000 mg and 12,000 mg of vitamin C per day respectively. Dr. Cheng expressed his wish of including the administration of oral vitamin C in future studies. This is because oral treatment can be given to more patients within the safety of their homes. You can learn more about it here!
Dr. Cheng, who’s also a US board-certified specialist in anti-aging medicine, mentioned that vitamin C is quite promising in the fight against COVID-19 and its prevention. He elaborated that it’s particularly useful in the treatment of critical patients with severe symptoms of COVID-19. This is particularly true in instances when there’s no other or better treatment plan that can be implemented.
According to De. Cheng, the world’s focus on finding a vaccine for the virus and specific antiviral drugs to deal with this pandemic is misplaced. Instead, administrations should look toward the administration of intravenous vitamin C to critical patients.
Cheng believes that early and appropriately large doses of intravenous vitamin C are critical for the survival of COVID-19 patients. Vitamin C is a prototypical antioxidant that’s involved in the prevention of viral replication and its eradication.
Large doses of IV vitamin C also help treat the most common cause of death by the different strands of coronavirus, such as MERS, SARS, and NPC. This cause is acute respiratory distress syndrome (ARDS).
A recent RCT carried out in the US in 167 patients suffering from sepsis-related ARDS revealed that the administration of 15 g of IV vitamin C per day for 4 consecutive days might decrease mortality in these patients.